Finding cancer early is just as important as treating it. The NHS Lung Cancer Screening programme, which is rolling out across Essex, proves it. This Lung Cancer Awareness Month, Carol Ord, Regional Programme Lead Lung Cancer Screening for the East of England, reveals how screening is helping fight against the biggest cancer killer in the UK.
Cancer is a vile thing, as we all know. Many of us know someone who has survived it, is living with it or has lost their live to it. Data suggests that nearly half of us will have cancer at some point in our lives. It is a sobering thought.
While better, more effective treatment is helping people with cancer to live longer, early detection through screening programmes also plays a huge part.
Since the introduction of such programmes, mortality rates have fallen. For example, the breast cancer screening programme has contributed to the decline in breast cancer deaths. Every year, breast screening detects around 19,000 cancers in England and prevents the deaths of around 1,300 women across the UK.
Screening is effective because treatment works best when cancers are found at an earlier stage. Screening allows us to find cancers before symptoms appear when they are easier to treat, and before they have spread.
Lung cancer screening – the newest cancer screening programme
Initially, NHS Lung Cancer Screening, previously known as Targeted Lung Health Checks, began as a very localised programme in a small number of areas in England, including Thurrock. The areas were chosen based on the high numbers of people with late-stage lung cancer diagnosis or high smoking rates. It invited people aged 55 to 74 who had a history of smoking, who are considered at higher risk of developing lung cancer.
Since then, the successful programme has expanded to more areas in Essex.
Why it is so important
Lung cancer is the third most common cancer diagnosed each year, but it is the most common cause of cancer death. Almost twice as many people die from lung cancer each year compared to bowel cancer, the second most common cause of death from cancer.
It often has no symptoms until later stages, or the symptoms are easily mistaken for other common conditions.
As treatment for lung cancer works best in the early stages, waiting for symptoms to appear can be too late. People diagnosed with stage 1 lung cancer have around a 65% chance of surviving for five years or more. This drops to around 15% at stage 3 and 5% at stage 4.
This is why screening is so important. It can pick up those early-stage cancers before they cause symptoms. People can then get the treatment they need when it will have the best chances.
In Essex, over 40,000 people have been invited to take part in screening. For most people screened, nothing will be found, but a small number will be diagnosed with cancer. So far, 449 lung cancers have been found through screening, with almost 75% being stage 1 or 2 (332). This impressive figure for early detection is having a profound effect.
Before the introduction of the programme, lung cancer was primarily diagnosed after a referral from a GP, emergency admissions and during investigations for other conditions. Just 23% of lung cancers were found at stage 1 or 2 via these routes in 2020.
Today the combined figure – including GP referrals, emergency admissions, chance discoveries, and lung cancer screening – is 43%; almost double the figure from six years ago. This will make a huge difference for people going through treatment, and we expect to see deaths from lung cancer reducing as a result.
How it works
Eligible people (55-74 and with a history of smoking) registered at participating GP practices receive an invitation letter asking them to schedule a telephone consultation with a specialist nurse. If they are considered at higher risk, they will be offered a low-dose CT scan, which is carried out at a state-of-the-art mobile unit.
The programme showcases the collaboration between many different organisations, including GP practices, hospital trusts and providers of the mobile scanning unit, Colbalt, working to deliver faster diagnosis for patients. Local government partners and the voluntary sector also play a crucial role in highlighting the importance of screening for eligible people.
What next for the programme
In 2023 the government announced the pilot programme would become part of the national screening programme with an ambition for full coverage by 2030. Since then, we have been working to expand the programme to all areas of Essex.
The recently announced arrival of the programme in Harlow is the first phase of a rollout to the whole of west Essex, including towns and communities in Epping Forest and Uttlesford.
We are now working on making lung screening part of our regular work. This includes reinviting people to the programme in areas it has already visited as well as inviting newly eligible people. It’s a real achievement for all the NHS professionals involved in delivering the programme and peace of mind and early treatment for those who need it most.